Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2006
05/24/2006EP1501812A4 Pna monomer and precursor
05/24/2006EP1487452B1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl -benzamide for treating seminomas
05/24/2006EP1485051A4 Method of administering buprenorphine to treat depression
05/24/2006EP1478613B1 Substituted 10-aryl-11h-benzo¬b|fluorenes for selective effects on estrogen receptors
05/24/2006EP1474425B1 Deazapurines and uses thereof
05/24/2006EP1471944B1 Pharmaceutical composition which improves in vivo gene transfer
05/24/2006EP1469886B1 Lyophilized pharmaceutical composition of propofol
05/24/2006EP1466614A4 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
05/24/2006EP1465577A4 Methods for improving the aesthetic appearance of skin
05/24/2006EP1458378B1 Amino acid derivatives useful for the treatment of alzheimer's disease
05/24/2006EP1414420B1 Method for the continuous production and coating of self-adhesive compounds on the basis of sbc that includes at least one pharmaceutically active substance
05/24/2006EP1409705B1 A process for the production of an inhibitor of human platelet aggregation and soybean lipoxygenase
05/24/2006EP1406888B1 Substituted y-lactone compounds serving as nmda antagonists
05/24/2006EP1397126B1 Use of tramadol for delaying ejaculation
05/24/2006EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity
05/24/2006EP1384477B1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
05/24/2006EP1370526B1 Diamides which inhibit tryptase and factor xa activity
05/24/2006EP1363912B1 Substituted imidazotriazinones
05/24/2006EP1355900B1 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
05/24/2006EP1341778B1 Klainetin and derivatives thereof, method for their production and the use of the same
05/24/2006EP1341544B1 Blocking the adsorption of germs in birds
05/24/2006EP1340504B1 Remedies for diabetes
05/24/2006EP1334106B1 Imidazole derivatives, production method thereof and use thereof
05/24/2006EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof
05/24/2006EP1325002B1 1,2,5,10-tetrahydropyridazino¬4,5-b|quinoline-1,10-diones and their use for the treatment of pain
05/24/2006EP1320529B1 Quinoline derivatives as antibacterials
05/24/2006EP1274322B1 Composition comprising free amino acids
05/24/2006EP1267836B1 Process for the preparation of accelerated release formulations using compressed fluids
05/24/2006EP1263801B1 Tissue bulking and coating compositions
05/24/2006EP1263413B1 Method of preparing solid dispersions
05/24/2006EP1259520B1 Novel purines
05/24/2006EP1257271B1 Use of pramipexole for the treament of tobacco/nicotine addiction
05/24/2006EP1254904B1 Novel piperidine compounds and drugs containing the same
05/24/2006EP1226129B1 Methods and compositions utilizing quinazolinones
05/24/2006EP1212298B1 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine
05/24/2006EP1196151B1 Transdermal therapeutic system for administering a calcium antagonist
05/24/2006EP1141305B1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum
05/24/2006EP1123696B1 Compositions for oral cavity
05/24/2006EP1115397B1 Compositions for mitigating the adverse effects of interleukin-2
05/24/2006EP1100492B1 INDOLE sPLA2 INHIBITORS
05/24/2006EP1100489B1 Method of altering nutritional components of milk produced by a lactating animal
05/24/2006EP1082118B1 Use of apomorphine in the treatment of premature ejaculation
05/24/2006EP1063971A4 Controlled release oral tablet having a unitary core
05/24/2006EP1061887B1 Novel use of phospholipids of vegetable and animal origin in nutritional therapy
05/24/2006EP1039887B1 Use of aminothiol compounds for the treatment of neuro- and nephro-disorders and therapeutic toxicities
05/24/2006EP1019058B1 Pharmaceutical suspension comprising nevirapine hemihydrate
05/24/2006EP0979652B1 Remedial composition for intraocular hypertension or glaucoma
05/24/2006EP0973563B1 System for dialysis and shock treatment
05/24/2006EP0946147B1 Composition suitable for the treatment of equine laminitis
05/24/2006EP0907733B1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/24/2006EP0892809B1 Fhit proteins and nucleic acids and methods based thereon
05/24/2006EP0858337B1 A pharmaceutical composition for the treatment of autoimmune diseases
05/24/2006EP0813539B1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom
05/24/2006DE4418796B4 Oral anwendbare und gegen Plaque und Gingivitis wirkende Zusammensetzungen An oral and acting against plaque and gingivitis compositions
05/24/2006DE20221551U1 Oil/water emulsion of lipophilic, unsaturated cosmetic agent, used in cosmetic or dermatological formulation for treating skin damaged by UV light and aging, contains glucose derivative and di- or poly-glycerol or ester as emulsifiers
05/24/2006DE202006004435U1 Foot care product in the form of creams, foam-creams, ointments and balsam, useful for treating diabetic foot syndrome with or without wounds, comprises urea and oregano oil
05/24/2006DE19543271B4 Orales pharmazeutisches Präparat An oral pharmaceutical composition
05/24/2006DE10248601B4 Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems A pharmaceutical composition for endonasal administration in the treatment of diseases and disorders of the central nervous system
05/24/2006DE102004056579A1 Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid Inhaled anticholinergic drugs containing a new, salmeterol, and a steroid
05/24/2006DE102004056578A1 Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid Inhaled medicines containing a new anticholinergic, formoterol and a steroid
05/24/2006DE102004056226A1 Neuartige Inhibitoren der Lysyloxidase Novel inhibitors of lysyl oxidase
05/24/2006DE102004055998A1 Niedermolekulare Inhibitoren von Guaninnucleotid-Austauschfaktoren der Cytohesin-Familie Small-molecule inhibitors of guanine nucleotide exchange factors of the cytohesin family
05/24/2006DE102004055858A1 Verwendung von langkettigen Alkoholen zur effektiven Senkung erhöhter Cholesterinspiegel Use of long chain alcohols for effectively lowering elevated cholesterol
05/24/2006DE102004054847A1 Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing
05/24/2006DE102004044884A1 Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen Substituted bicyclic imidazo-3-yl-amine compounds
05/24/2006CN1777671A Novel galactooligosaccharide composition and the preparation thereof
05/24/2006CN1777622A Modulation of the poliovirus receptor function
05/24/2006CN1777618A 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos
05/24/2006CN1777614A Substituted benzopyrans as selective estrogen receptor-beta agonists
05/24/2006CN1777613A New polymorphs of olanzapine hydrochloride
05/24/2006CN1777612A New piperidinylamino-thieno[2,3-d] pyrimidine compounds
05/24/2006CN1777611A Novel process for the preparation of hexacyclic camptothecin
05/24/2006CN1777609A 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
05/24/2006CN1777608A Fused pyrimidine derivative
05/24/2006CN1777607A Substituted 8 -pyridinyl-dihydrospiro- cycloalkyl -pyrimido 1,2-a pyrimidin-6-one and 8 -pyrimidin yl-dihydrospiro- cycloalkyl -pyrimido 1,2-a pyrimidin-6-one derivatives
05/24/2006CN1777606A 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo [2, 3d]pyrimidine hydrogen mesylate and its polymorphic forms
05/24/2006CN1777605A Cannabined receptor ligands and uses thereof
05/24/2006CN1777603A Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
05/24/2006CN1777602A Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
05/24/2006CN1777600A 4-, 6- o 7-hydroxyindoles having n-oxide groups and the use thereof as therapeutic agents
05/24/2006CN1777599A 5-hydroxyindoles with n-oxide groups and use thereof as a phosphodiesterase 4 inhibitor
05/24/2006CN1777598A Polymorphs of s-omeprazole.
05/24/2006CN1777597A Indazole having analgesic activity
05/24/2006CN1777596A Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders
05/24/2006CN1777595A Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
05/24/2006CN1777594A Synthesis of quetiapine and pharmaceutically acceptable salts thereof
05/24/2006CN1777593A Acylaminothiazole derivatives, their preparation and their use as beta starchy peptide to produce inhibitor
05/24/2006CN1777590A Indazole derivatives
05/24/2006CN1777585A 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
05/24/2006CN1777584A (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht 1f agonists
05/24/2006CN1777582A Substituted indoline and indole derivatives
05/24/2006CN1777581A Remedy for diabetes
05/24/2006CN1777580A Prostaglandin derivatives
05/24/2006CN1777577A Antibacterial agents
05/24/2006CN1777575A Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
05/24/2006CN1777447A Methods and immune modulatory nucleic acid compositions for preventing and treating disease
05/24/2006CN1777446A A medicament for the two-step perioperative therapy of solid tumours
05/24/2006CN1777445A Agent for repairing corneal perception
05/24/2006CN1777443A Methods of diagnosing and treating pre-eclampsia or eclampsia
05/24/2006CN1777440A Method for preparation of site-specific protein conjugates